For the 2024 reporting year, the following ASCO measures are available in the Merit-based Incentive Payment System (MIPS) reporting program. Select ASCO measures are also included in the MIPS Oncology/Hematology Specialty Measure Set, as well as the Advancing Cancer Care MVP.
MIPS Value Pathways (MVPs) are a reporting option to fulfill MIPS reporting requirements. Each MVP consists of a subset of measures and activities related to a specialty or medical condition.
The Advancing Cancer Care MVP focuses on the treatment and management of cancer care. The measures included in this MVP assess three critical areas: 1) the patient experience of care, 2) end of life care, and 3) appropriate diagnostics along with possible treatment options for different cancer diagnoses.
The MIPS Oncology/Hematology Specialty Measure Set can be viewed by selecting Oncology/Hematology from the Specialty Measure Set dropdown list at Explore Measures & Activities (cms.gov). The CMS MIPS historical quality benchmarks for ASCO MIPS measures are available at Benchmarks (cms.gov).
MIPS Clinical Quality Measures (CQMs) and electronic Clinical Quality Measures (eCQMs)
These oncology measures are available for reporting to CMS in the MIPS program.
Quality ID (QPP/CBE) |
Measure Title |
Availability |
---|---|---|
QPP 143 (CBE 0384) |
Oncology: Medical and Radiation-Pain Intensity Quantified (CQM) |
|
CMS157v10 (CBE 0384e) |
Oncology Medical and Radiation-Pain Intensity Quantified (eCQM) |
|
QPP 144 (CBE 0383) |
Oncology: Medical and Radiation-Plan of Care for Pain (CQM) |
|
QPP 450 (CBE 1858) |
Appropriate Treatment for Patients with Stage I (T1c)-III HER2 Positive Breast Cancer (CQM) |
|
QPP 451 (CBE 1859) |
|
|
QPP 452 (CBE 1860) |
|
|
QPP 453 (CBE 0210) |
|
|
QPP 457 (CBE 0216) |
|